Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 6Melanoma 6Colorectal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Neoplasms 3Head and Neck Neoplasms 3Colonic Neoplasms 3Uterine Cervical Dysplasia 2Skin Neoplasms 2Sarcoma, Kaposi 2Sarcoma 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Inflammatory Breast Neoplasms 2HIV Infections 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Unspecified Adult Solid Tumor, Protocol Specific 1Turcot syndrome 1Thrombocytosis 1

Interventions

pembrolizumab 3Nivolumab 3Ipilimumab 3Cyclophosphamide 3Radiosurgery 2MART-1 Antigen 2CTLA-4 Antigen 2ulixertinib 1sotrastaurin 1siremadlin 1relatlimab 1pentetreotide 1oblimersen 1incomplete Freund's adjuvant 1fotemustine 1fludarabine phosphate 1fludarabine 1entrectinib 1defactinib 1binimetinib 1benzamide 1aldesleukin 1aflibercept 1Valacyclovir 1Toll-Like Receptor 1 1TYRP1 protein, human 1Sunitinib 1Standard of Care 1RO5126766 1RNA, Messenger 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Uveal Melanoma × Biopsy × Clear all
NCT04720417 2025-07-15

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma

Thomas Jefferson University

Phase 2 Terminated
13 enrolled 13 charts
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡